Ovarian Cancer Trial, Recruiting NCT07469709 Sponsor: Fondazione del Piemonte per l'Oncologia Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07469709
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You have been diagnosed with breast cancer, including if you meet certain guidelines that qualify you for a genetic (BRCA) test, or if you have a specific type called lobular breast cancer
  • You have colon cancer that has been fully removed by surgery, including if your cancer was at an advanced local stage (stage III) or showed signs of spreading into blood vessels
  • You have been diagnosed with ovarian cancer
  • You have melanoma (a type of skin cancer) that has spread to other parts of the body
  • You have a type of lung cancer called non-small cell lung cancer at stage IIB or IIIA

Who may not be able to join:

  • You are under 18 years old
  • You are unable or unwilling to sign a consent form agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chiara Lazzari, MD, Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo

Phone: +390119933915

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione del Piemonte per l'Oncologia
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
1 May 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Number, frequency and type of genetic variants in known genes not detected by routine diagnostic tests for hereditary tumours

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov